Cat. No. | Product name | CAS No. |
DCC1566 |
Cremastranone
Natural antiangiogenic homoisoflavanone, inhibiting the proliferation, migration and tube formation ability of human retinal microvascular endothelial cells |
107585-69-3 |
DCC1567 |
Cribrostatin 6
Antineoplastic and Antibacterial; Inducer of death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism; Dark blue cancer cell growth inhibitor |
518056-45-6 |
DCC1568 |
Crl-40940
Selective dopaminergic reuptake inhibitor |
90280-13-0 |
DCC1569 |
Crom-1
Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B) |
|
DCC1570 |
Crom-2
Novel potent, selective, and reversible inhibitor of human monoamine oxidase B (hMAO-B) |
|
DCC1571 |
Crs400359
Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, improving the antimycobacterial activity and being also potent against Mtb |
|
DCC1572 |
Crs400393
Novel potent and mycobacteria-specific antimycobacterial agent, targeting MmpL3, a mycobacterial mycolic acid transporterr, demonstrating MIC = 0.03, 2, and ≤ 0.12 μg/mL against Mabs, Mycobacterium avium complex (MAC), and Mtb respectively |
2253175-64-1 |
DCC1573 |
Crt0083914
Potent and selective inhibitor of AKR1C3 |
932495-16-4 |
DCC1574 |
Crt0093964
Potent and selective inhibitor of AKR1C3 |
700856-05-9 |
DCC1575 |
Crth2 Antagonist K117
Potent and selective CRTH2 antagonist |
308289-84-1 |
DCC1576 |
Crx-526
TLR4 antagonist, protecting against advanced diabetic nephropathy |
245515-64-4 |
DCC1577 |
Crx-527
Novel potent powerful lipid A analogue as a conjugation-ready TLR4 ligand |
|
DCC1578 |
Cryosim-1
Novel TRPM8 agonist |
1487170-15-9 |
DCC1579 |
Cryosim-3
Novel water-soluble, potent, and selective TRPM8 receptor agonist |
1507344-37-7 |
DCC1580 |
Cryptopleurine
Inhibitor of gene products associated with cell survival, proliferation, invasion, and angiogenesis, targeting NF-κB pathway, showing antiproliferative activity and unique mode of action |
482-22-4 |
DCC1581 |
Cryptozepine-2
Novel photoisomerizable potent and selective M1 ligand, mimicing the tricyclic chemical structure and display reversibly controlled activity, showing stronger inhibition upon illumination both in vitro and in cardiac atria ex vivo |
|
DCC1582 |
Csl-32
Novel modulator of PI3K and NF-κB activities, blocking migration and production of inflammatory mediators |
|
DCC1583 |
C-src-in-12
Novel substrate-competive c-Src inhibitor |
|
DCC1584 |
Csv0c018875 Hydrochloride
Novel G9a (EHMT2) inhibitor, binding tightly inside the active site cavity of G9a, inhibiting the activity of G9a in both enzyme and cell based assays with much lesser toxicity than BIX-0129 |
474084-56-5 |
DCC1585 |
Ct-2584
Dual inhibitor of angiogenesis and lysophosphatidic acid acyltransferase |
166981-13-1 |
DCC1586 |
Ct-711
Novel potent dual inhibitor of ALK and c-Met |
|
DCC1587 |
Ct-mz1
Novel cell permeable degrader of BRD4 |